Article
[Research progresses of the PARP inhibitors for the treatment of cancer].
Yao xue xue bao = Acta pharmaceutica Sinica - 1 May 2013
He Yu-Jun, Liu Rui-Huan, Ning Cheng-Qing, Yu Nie-Fang
Abstract excerpt
The poly(ADP-ribose) polymerases (PARPs) is an important group of enzymes in DNA repair pathways, especially the base excision repair (BER) for DNA single-strand breaks (SSBs) repair. Inhibition of PARP in DNA repair-defective tumors (like those with BRAC1/2 mutations) can lead to cell death and genomic instability, what is so called "synthetic lethality". Currently, PARP inhibitors combined with cytotoxic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
